A peptide from centipede venom kills E. coli not by punching holes in membranes but by generating toxic oxygen radicals that trigger bacterial suicide.
Zero hemolysisLBLP killed E. coli potently while showing no toxicity to human red blood cells
What the researchers found
LBLP kills E. coli through ROS-induced apoptosis-like death rather than membrane disruption, and shows no hemolytic toxicity to human erythrocytes.
Why it matters
Antibiotic resistance is a growing global crisis. Peptides with novel killing mechanisms — like triggering bacterial suicide rather than membrane lysis — could yield antibiotics that are harder for bacteria to evolve resistance against.
The numbers in context
23-mer AMP; potent anti-E. coli activity; no hemolysis; ROS-dependent apoptosis-like death; NAC reversed killing
How the study worked
In vitro antibacterial assays against E. coli with mechanistic studies including ROS measurement, membrane depolarization, DNA fragmentation, caspase-like protein activation, and phosphatidylserine exposure. NAC (ROS scavenger) used to confirm mechanism.
Who was studied
E. coli cultures and human erythrocytes
What this study cannot tell us
In vitro only — no animal infection model tested; only tested against E. coli; concentration-dependent toxicity profile not fully characterized.
How to read the evidence
Preliminary — in vitro mechanistic study only; no animal or clinical data.
When this study was published
Published in 2020; venom-derived AMPs continue to be an active research area.
The bigger picture
Venom-derived antimicrobial peptides represent a largely untapped reservoir of potential antibiotics. Understanding their unique mechanisms helps design next-generation antimicrobials.
Questions still open
- Does LBLP work against antibiotic-resistant E. coli strains like ESBL producers?
- Can bacteria develop resistance to ROS-mediated killing?
- What is the peptide's stability and half-life in biological fluids?
Common questions
How is this peptide different from regular antibiotics?
Is it safe for humans?
Read the original research
Antibacterial action of lactoferricin B like peptide against Escherichia coli: reactive oxygen species-induced apoptosis-like death.
Journal of applied microbiology, 129(2), 287-295
Citation
Lee, B; Hwang, J S; Lee, D G. (2020). Antibacterial action of lactoferricin B like peptide against Escherichia coli: reactive oxygen species-induced apoptosis-like death.. Journal of applied microbiology, 129(2), 287-295. https://doi.org/10.1111/jam.14632